| 000 | 01671 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513055413.0 | ||
| 264 | 0 | _c19940822 | |
| 008 | 199408s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diab.43.8.1027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, H Y | |
| 245 | 0 | 0 |
_aEndothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. _h[electronic resource] |
| 260 |
_bDiabetes _cAug 1994 |
||
| 300 |
_a1027-32 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta _xdrug effects |
| 650 | 0 | 4 |
_aArginine Vasopressin _xpharmacology |
| 650 | 0 | 4 |
_aCycloheximide _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEndothelins _xpharmacology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xpharmacology |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor II _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesenteric Arteries _xdrug effects |
| 650 | 0 | 4 | _aPerfusion |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 700 | 1 | _aJeng, Y Y | |
| 700 | 1 | _aYue, C J | |
| 700 | 1 | _aChyu, K Y | |
| 700 | 1 | _aHsueh, W A | |
| 700 | 1 | _aChan, T M | |
| 773 | 0 |
_tDiabetes _gvol. 43 _gno. 8 _gp. 1027-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diab.43.8.1027 _zAvailable from publisher's website |
| 999 |
_c8038917 _d8038917 |
||